Bio-Path Holdings, Inc. (BPTH)
NASDAQ: BPTH · IEX Real-Time Price · USD
1.790
-0.010 (-0.56%)
Jul 22, 2024, 10:06 AM EDT - Market open
Bio-Path Holdings Employees
Bio-Path Holdings had 10 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
10
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,396,200
Market Cap
3.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
Regional Health Properties | 114 |
Fresh2 Group | 75 |
Applied DNA Sciences | 55 |
iSpecimen | 53 |
Sintx Technologies | 43 |
Scinai Immunotherapeutics | 31 |
Onconetix | 12 |
BPTH News
- 14 days ago - Bio-Path Holdings Provides Clinical Update and Expansion Plans - GlobeNewsWire
- 5 weeks ago - Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress - GlobeNewsWire
- 6 weeks ago - Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 6 weeks ago - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24 - Newsfile Corp
- 7 weeks ago - Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 months ago - Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress - GlobeNewsWire
- 2 months ago - Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 months ago - Bio-Path Holdings Reports First Quarter 2024 Financial Results - GlobeNewsWire